Published in Dtsch Med Wochenschr on January 18, 1985
The neuropathology of AIDS. UCLA experience and review. Am J Pathol (1986) 2.08
Lectins from Synadenium carinatum (ScLL) and Artocarpus heterophyllus (ArtinM) Are Able to Induce Beneficial Immunomodulatory Effects in a Murine Model for Treatment of Toxoplasma gondii Infection. Front Cell Infect Microbiol (2016) 0.75
Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection. Infection (1991) 3.29
Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS (1997) 2.59
Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes (1994) 2.16
The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. J Immunol (1990) 2.11
In vitro activity of HR 756, a new cephalosporin compound. J Antibiot (Tokyo) (1978) 1.98
Isolation frequency and growth properties of HIV-variants: multiple simultaneous variants in a patient demonstrated by molecular cloning. J Med Virol (1987) 1.92
[Clinic and diagnosis of enteric infections in man by Yersinia enterocolitica (author's transl)]. Infection (1973) 1.90
Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis (1997) 1.79
Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. J Biol Chem (1998) 1.73
Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J Exp Med (1993) 1.67
[Syrian hamsters as vectors of lymphocytic choriomeningitis]. Dtsch Med Wochenschr (1972) 1.56
Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1. J Exp Med (1993) 1.52
Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival. AIDS (1998) 1.51
An infectious disease transmitted by Cercopithecus aethiops. ("Green monkey disease"). Ger Med Mon (1968) 1.47
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J Exp Med (1992) 1.46
Sex hormones as a cofactor in the pathogenesis of epidemic Kaposi's sarcoma. AIDS (1995) 1.43
The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity (2000) 1.40
Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.38
Multiple sclerosis and Chlamydia pneumoniae. Ann Neurol (2000) 1.37
[Clinical experience with a new cephalosporin derivative, Cefotaxim]. Med Welt (1979) 1.33
I-E+ nonobese diabetic mice develop insulitis and diabetes. J Exp Med (1993) 1.32
In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid. Eur J Clin Microbiol (1983) 1.26
Isolation of variants of lymphocytopathic retroviruses from the peripheral blood and cerebrospinal fluid of patients with ARC or AIDS. J Med Virol (1986) 1.26
Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J Infect Dis (1986) 1.22
4-quinolones inhibit biotransformation of caffeine. Eur J Clin Pharmacol (1988) 1.14
Genetic control of diabetes and insulitis in the nonobese diabetic mouse. Pedigree analysis of a diabetic H-2nod/b heterozygote. J Immunol (1989) 1.12
Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins. J Antimicrob Chemother (1983) 1.10
Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study. Eur J Med Res (2000) 1.10
Effect of aminoglycosides on proximal tubular membranes of the human kidney. Eur J Clin Pharmacol (1978) 1.09
Virological response to protease inhibitor therapy in an HIV clinic cohort. AIDS (1999) 1.09
Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. Science (1993) 1.08
Clinical experience with cefotaxime in internal medicine between 1981 and 1984. Drugs (1988) 1.07
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. Eur J Clin Microbiol Infect Dis (1991) 1.06
Activity of amikacin at sub-inhibitory levels. J Antimicrob Chemother (1976) 1.03
[Paradoxic bactericidal effect of penicillins on enterococci (Eagle effect)]. Dtsch Med Wochenschr (1973) 1.03
Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma (2001) 0.98
[Bactericidal dosie-activity relationships with E. coli, K. pneumoniae and Staph. aureus (author's transl)]. Dtsch Med Wochenschr (1976) 0.96
[Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study]. Dtsch Med Wochenschr (1984) 0.96
Relationship between multiple biologic effects of rapamycin and the inhibition of pp70S6 protein kinase activity. Analysis in mutant clones of a T cell lymphoma. J Immunol (1994) 0.95
Immunoglobulin class- and subclass-specific HIV antibody detection in serum and CSF specimens by ELISA and Western blot. Infection (1987) 0.95
MRI in human immunodeficiency virus-associated cerebral vasculitis. Neuroradiology (2000) 0.95
Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr (1993) 0.95
[Therapy of systemic mycoses in immunodeficiency]. Immun Infekt (1991) 0.94
Metronome in Parkinson's disease. Lancet (1996) 0.94
Cryptococcus meningoencephalitis in AIDS: parenchymal and meningeal forms. Neuroradiology (1999) 0.93
Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol Med (1997) 0.93
HIV-2 (West Germany, 1984) Lancet (1987) 0.93
Efficacy of antibiotics in bacteriobilia. J Antimicrob Chemother (1982) 0.92
Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients. Mycoses (1991) 0.92
Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission. A report of 10 cases and review of the literature. Genitourin Med (1994) 0.91
Autochthonic Mediterranean spotted fever in West Germany. Lancet (1984) 0.91
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort. Eur J Med Res (2009) 0.91
Neurological complications in AIDS. J Neurol (1987) 0.89
Alternating treatment of common bile duct stones with a modified glyceryl-1-monooctanoate preparation and a bile acid-EDTA solution by nasobiliary tube. Scand J Gastroenterol (1981) 0.87
[Oyster-transmitted hepatitis]. Dtsch Med Wochenschr (1972) 0.87
Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies. J Antimicrob Chemother (1996) 0.87
Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085. Neurology (1983) 0.87
The significance of cerebral atrophy for the symptomatology of Parkinson's disease. J Neurol Sci (1979) 0.87
Effect of concentration on bactericidal activity of cefotaxime. J Antimicrob Chemother (1979) 0.86
[On an infectious disease transmitted by Cercopithecus aethiops. ("Green monkey disease")]. Dtsch Med Wochenschr (1968) 0.86
Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clin Investig (1992) 0.85
[Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis]. Mycoses (1996) 0.85
Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes. J Pharmacol Exp Ther (1994) 0.85
Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1993) 0.85
Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferon. Onkologie (1986) 0.85
Treatment of oral 'hairy' leukoplakia in AIDS patients with vitamin A acid (topically) or acyclovir (systemically) Dermatologica (1987) 0.84
Increase in Vdelta1+ gammadelta T cells in the peripheral blood and bone marrow as a selective feature of HIV-1 but not other virus infections. Br J Haematol (1998) 0.84
[Intestinal permeability in patients with acquired immunodeficiency syndrome (AIDS)]. Klin Wochenschr (1991) 0.84
Lamotrigine--antiparkinsonian activity by blockade of glutamate release? J Neural Transm Park Dis Dement Sect (1993) 0.84
[Pathogen elimination after surgical interventions on common bile duct (author's transl)]. Langenbecks Arch Chir (1979) 0.84
HIV transmission from male after only two sexual contacts. Lancet (1987) 0.83
[Shunt sepsis. On the clinical aspects of septic complications of intermittent hemodialysis]. Dtsch Med Wochenschr (1967) 0.83
[In vitro studies on intermittent therapy with penicillin G and ampicillin]. Med Welt (1978) 0.83
[Spontaneous course of LAV/HTLV-III infection. Follow-up of persons from AIDS-risk groups]. Dtsch Med Wochenschr (1986) 0.83
Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy. Ann Hematol (1994) 0.83
Demonstration of cross-reactive antibodies able to elicit lysis of both HIV-1- and HIV-2-infected cells. J Immunol (1990) 0.82
Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts. Eur J Med Res (1995) 0.82
TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of T-cell depletion in HIV infected individuals. Eur J Med Res (1996) 0.82
[Ciprofloxacin and imipenem in nocardiosis]. Dtsch Med Wochenschr (1987) 0.82
Unexpected up-regulation of gene expression by cyclosporin A and FK-506 in a T-cell lymphoma: both immunosuppressants augment Ly-6E antigen induction by interferon-gamma in the presence of ionomycin. Int J Immunopharmacol (1991) 0.82
Interaction between quinolones and caffeine. Drugs (1987) 0.82
Kinetics of bacterial elimination in urine during antimicrobial treatment. J Antimicrob Chemother (1979) 0.82
Positioning of the beta-lactam antibiotics. Infection (1985) 0.82